相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies
John Hilton et al.
NATURE COMMUNICATIONS (2022)
The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure
Susie L. Brown et al.
PHARMACEUTICALS (2021)
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Min Pan et al.
NATURE COMMUNICATIONS (2021)
Transcription-associated topoisomerase 2α a (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands
Madeleine Bossaert et al.
ELIFE (2021)
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
Peter M. Bruno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Genetic Map of the Response to DNA Damage in Human Cells
Michele Olivieri et al.
CELL (2020)
The Structure and Function of DNA G-Quadruplexes
Jochen Spiegel et al.
TRENDS IN CHEMISTRY (2020)
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
Amit Khot et al.
CANCER DISCOVERY (2019)
The Interplay between G-quadruplex and Transcription
Nayun Kim
CURRENT MEDICINAL CHEMISTRY (2019)
DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells
Alessio De Magis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Hong Xu et al.
NATURE COMMUNICATIONS (2017)
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
Jutta Zimmer et al.
MOLECULAR CELL (2016)
G-Quadruplex DNA as a Molecular Target for Induced Synthetic Lethality in Cancer Cells
Keith I. E. McLuckie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth
Denis Drygin et al.
CANCER RESEARCH (2011)
Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
Denis Drygin et al.
CANCER RESEARCH (2009)
Identification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein
Veronica Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Importance of Negative Superhelicity in Inducing the Formation of G-Quadruplex and i-Motif Structures in the c-Myc Promoter: Implications for Drug Targeting and Control of Gene Expression
Daekyu Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Dissecting the cell-killing mechanism of the topoisomerase II-targeting drug ICRF-193
VH Oestergaard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription
A Siddiqui-Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Selective interactions of cationic porphyrins with G-quadruplex structures
HY Han et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
G-quadruplexes as targets for drug design
LH Hurley et al.
PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
